Gil Blum
Stock Analyst at Needham
(4.18)
# 661
Out of 5,182 analysts
433
Total ratings
43.66%
Success rate
18.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LYEL Lyell Immunopharma | Initiates: Buy | $44 | $22.77 | +93.24% | 1 | Apr 10, 2026 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.42 | +604.23% | 36 | Apr 9, 2026 | |
| ABSI Absci | Reiterates: Buy | $7 | $4.85 | +44.33% | 10 | Mar 30, 2026 | |
| CELC Celcuity | Reiterates: Buy | $122 | $125.68 | -2.93% | 24 | Mar 26, 2026 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $18 | $10.75 | +67.44% | 8 | Mar 11, 2026 | |
| IMCR Immunocore Holdings | Maintains: Buy | $71 → $75 | $28.56 | +162.61% | 15 | Feb 26, 2026 | |
| ACLX Arcellx | Downgrades: Hold | n/a | $115.07 | - | 26 | Feb 23, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $80 → $82 | $50.99 | +60.82% | 28 | Feb 13, 2026 | |
| MREO Mereo BioPharma Group | Maintains: Buy | $5 → $3 | $0.28 | +970.66% | 21 | Jan 13, 2026 | |
| GERN Geron | Reiterates: Buy | $6 | $1.53 | +292.16% | 23 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $16.49 | +57.67% | 31 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $2.83 | +288.69% | 19 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | n/a | $20.98 | - | 39 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.50 | +153.33% | 4 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $6.46 | +85.76% | 33 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $42 | $7.07 | +494.06% | 17 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.48 | +129.89% | 26 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $14.49 | - | 8 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $6 | $1.31 | +358.02% | 8 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.31 | - | 9 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | n/a | $3.49 | - | 22 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.72 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $9.62 | +398.96% | 9 | Aug 2, 2024 |
Lyell Immunopharma
Apr 10, 2026
Initiates: Buy
Price Target: $44
Current: $22.77
Upside: +93.24%
Autolus Therapeutics
Apr 9, 2026
Reiterates: Buy
Price Target: $10
Current: $1.42
Upside: +604.23%
Absci
Mar 30, 2026
Reiterates: Buy
Price Target: $7
Current: $4.85
Upside: +44.33%
Celcuity
Mar 26, 2026
Reiterates: Buy
Price Target: $122
Current: $125.68
Upside: -2.93%
Artiva Biotherapeutics
Mar 11, 2026
Reiterates: Buy
Price Target: $18
Current: $10.75
Upside: +67.44%
Immunocore Holdings
Feb 26, 2026
Maintains: Buy
Price Target: $71 → $75
Current: $28.56
Upside: +162.61%
Arcellx
Feb 23, 2026
Downgrades: Hold
Price Target: n/a
Current: $115.07
Upside: -
CRISPR Therapeutics AG
Feb 13, 2026
Maintains: Buy
Price Target: $80 → $82
Current: $50.99
Upside: +60.82%
Mereo BioPharma Group
Jan 13, 2026
Maintains: Buy
Price Target: $5 → $3
Current: $0.28
Upside: +970.66%
Geron
Aug 9, 2024
Reiterates: Buy
Price Target: $6
Current: $1.53
Upside: +292.16%
Apr 23, 2026
Reiterates: Buy
Price Target: $26
Current: $16.49
Upside: +57.67%
Mar 26, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $2.83
Upside: +288.69%
Mar 26, 2026
Reiterates: Underperform
Price Target: n/a
Current: $20.98
Upside: -
Mar 20, 2026
Reiterates: Buy
Price Target: $19
Current: $7.50
Upside: +153.33%
Mar 19, 2026
Maintains: Buy
Price Target: $10 → $12
Current: $6.46
Upside: +85.76%
Mar 9, 2026
Reiterates: Buy
Price Target: $42
Current: $7.07
Upside: +494.06%
Feb 26, 2026
Reiterates: Buy
Price Target: $8
Current: $3.48
Upside: +129.89%
Dec 19, 2025
Downgrades: Hold
Price Target: n/a
Current: $14.49
Upside: -
Nov 4, 2025
Maintains: Buy
Price Target: $9 → $6
Current: $1.31
Upside: +358.02%
Oct 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.31
Upside: -
Jul 24, 2025
Maintains: Hold
Price Target: n/a
Current: $3.49
Upside: -
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.72
Upside: -
Aug 2, 2024
Reiterates: Buy
Price Target: $48
Current: $9.62
Upside: +398.96%